UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4726-4734

2005

Volltextzugriff (PDF)

Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study

European journal of cancer (1990), 2006-11, Vol.42 (17), p.3004-3014

2006

Volltextzugriff (PDF)

Cross‐cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3

International journal of cancer, 1999, Vol.83 (S12), p.112-118

1999

Volltextzugriff (PDF)

PIH33 - Utility Values for Health Technology Assessment: Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

Value in health, 2015-11, Vol.18 (7), p.A738-A738

2015

Volltextzugriff (PDF)

Avis d’efficience relatifs aux produits de santé à la Haute Autorité de santé : bilan et perspectives

Santé publique (Vandoeuvre-lès-Nancy, France), 2015-12, Vol.27 (5), p.691-700

2015

Volltextzugriff (PDF)

Social acceptability of HIV screening among pregnant women

AIDS care, 1990-08, Vol.2 (3), p.213-222

1990

Volltextzugriff (PDF)

Utility Values for Health Technology Assessment: Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

Value in health, 2015-11, Vol.18 (7), p.A738-A738

2015

Volltextzugriff (PDF)

Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: Protocol of the study of the French Society of Clinical Cytology

Diagnostic cytopathology, 2001-06, Vol.24 (6), p.412-420

2001

Volltextzugriff (PDF)

French Cross-Cultural Adaptation of the Health Utilities Indexes Mark 2 (HUI2) and 3 (HUI3) Classification Systems

Quality of life research, 1998-04, Vol.7 (3), p.245-256

1998

Volltextzugriff (PDF)

Reliability and Validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French Cancer Patients

Quality of life research, 2005-06, Vol.14 (5), p.1427-1432

2005

Volltextzugriff (PDF)

Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening: A study by the French Society of Clinical Cytology

American journal of clinical pathology, 2003-10, Vol.120 (4), p.492-499

2003

Volltextzugriff (PDF)

dépistage de l'infection à VIH et grossesse

Journal de pédiatrie et de puériculture, 1991-03, Vol.4 (2), p.85-90

1991

Volltextzugriff (PDF)

Economic assessment of maternal serum screening for Down's syndrome using human chorionic gonadotropin

Prenatal diagnosis, 1993-04, Vol.13 (4), p.281-292

1993

Volltextzugriff (PDF)

Intérêts d'un indicateur d'états de santé pour les enfants atteints de maladie grave: l'exemple des tumeurs cérébrales

Archives de pédiatrie (Paris), 2000-05, Vol.7, p.242s-243s

LE GALES, C

2000

Volltextzugriff (PDF)

How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

Value in health, 2016-11, Vol.19 (7), p.A376-A376

2016

Volltextzugriff (PDF)

PRM106 - How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

Value in health, 2016-11, Vol.19 (7), p.A376-A376

2016

Volltextzugriff (PDF)

Fighting chronic disease

Bulletin of the World Health Organization, 2005-06, Vol.83 (6), p.407-408

Le Galès-Camus, Catherine

2005

Volltextzugriff (PDF)

Influenza burden of illness: estimates from a national prospective survey of household contacts in France

Archives of internal medicine (1960), 2002-09, Vol.162 (16), p.1842

2002

Volltextzugriff (PDF)

Reliability and Discriminant Validity of the French Version of Fact-G in Cancer Patients

Quality of life research, 2000-03, Vol.9 (3), p.288-288

2000

Volltextzugriff (PDF)

Cost of screening for cancerous and precancerous lesions of the cervix

Diagnostic cytopathology, 2002-10, Vol.27 (4), p.251-257

2002

Volltextzugriff (PDF)

QALY's Models: Theoretical and Empirical Issues of a Preference Approach

Quality of life research, 1995-10, Vol.4 (5), p.404-404

1995

Volltextzugriff (PDF)

Social and economic aspects of osteoporosis

Current opinion in rheumatology, 1998-07, Vol.10 (4), p.362-367

1998

Volltextzugriff (PDF)

Social perception of AIDS in the general public: a French study

Health policy (Amsterdam), 1988, Vol.9 (1), p.1-8

1988

Volltextzugriff (PDF)

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area

European journal of obstetrics & gynecology and reproductive biology, 1990-10, Vol.37 (1), p.25-33

1990

Volltextzugriff (PDF)

Cost-Effectiveness of Liquid-Based Cytology with or without Hybrid-Capture II HPV Test Compared with Conventional Pap Smears: A Study by the French Society of Clinical Cytology

Journal of lower genital tract disease, 2006-04, Vol.10 (2), p.129

2006

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(208)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study

Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study

Cross‐cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3

PIH33 - Utility Values for Health Technology Assessment: Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

Avis d’efficience relatifs aux produits de santé à la Haute Autorité de santé : bilan et perspectives

Social acceptability of HIV screening among pregnant women

Utility Values for Health Technology Assessment: Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: Protocol of the study of the French Society of Clinical Cytology

French Cross-Cultural Adaptation of the Health Utilities Indexes Mark 2 (HUI2) and 3 (HUI3) Classification Systems

Reliability and Validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French Cancer Patients

Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening: A study by the French Society of Clinical Cytology

dépistage de l'infection à VIH et grossesse

Economic assessment of maternal serum screening for Down's syndrome using human chorionic gonadotropin

Intérêts d'un indicateur d'états de santé pour les enfants atteints de maladie grave: l'exemple des tumeurs cérébrales

How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

PRM106 - How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

Fighting chronic disease

Influenza burden of illness: estimates from a national prospective survey of household contacts in France

Reliability and Discriminant Validity of the French Version of Fact-G in Cancer Patients

Cost of screening for cancerous and precancerous lesions of the cervix

QALY's Models: Theoretical and Empirical Issues of a Preference Approach

Social and economic aspects of osteoporosis

Social perception of AIDS in the general public: a French study

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area

Cost-Effectiveness of Liquid-Based Cytology with or without Hybrid-Capture II HPV Test Compared with Conventional Pap Smears: A Study by the French Society of Clinical Cytology

Suchergebnisse filtern